Диссертация (1146694), страница 23
Текст из файла (страница 23)
Penco et al. // World Journal of Cardiology. –2016. – V. 8. – №. 2. – P. 114 – 119.136. Mehta S. R. Effect of Glucose-Insulin-Potassium Infusion on Mortality inPatients With Acute ST-Segment Elevation Myocardial Infarction. The CREATEECLA Randomized Controlled Trial: The CREATE-ECLA randomized controlledtrial / S. R.
Mehta, S.Yusuf, R. Diaz, J. Zhu, P. Pais, D. Xavier, E. Paolasso, R.Ahmed, C. Xie, K. Kazmi, J. Tai, A. Orlandini, J. Pogue, L. Liu; CREATE-ECLAtrial group investigators // JAMA. – 2005. – V. 293. – № 4. – Р. 437 – 446.137. Miller P.E. Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid andDocosahexaenoic Acid and Blood Pressure: A Meta-Analysis of RandomizedControlled Trials / P.E. Miller, M. V. Elswyk, D.D. Alexander // American Journalof Hypertension.
– 2014. – № 27(7). – Р. 885 – 896.138. Molfino A. The role for dietary omega-3 fatty acids supplementation inolder adults / A. Molfino, G. Gioia, F.R. Fanelli, M. Muscaritoli // Nutrients. –2014. – № 6. – Р. 4058–4073.148139. Mosterd A. Clinical epidemiology of heart failure / A. Mosterd, A. W. Hoes// Heart. – 2007. – V.
93. – P. 1137 – 1146.140. Mozaffarian D. Dietary fish and n-3 fatty acid consumption and heart ratevariability in US adults / D. Mozaffarian, P. K. Stein, R. J. Prineas, D. S. Siscovick// Circulation. – 2008. – V. 117. – № 9. – P. 1130-1137.141. Naini А.Е. Effect of Omega-3 fatty acids on blood pressure and serum lipidsin continuous ambulatory peritoneal dialysis patients / A.E.
Naini, N.Keyvandarian, M. Mortazavi, S. Taheri, S. M. Hosseini // Journal of Research inPharmacy Practice. – 2015. – №4(3). – Р. 135 – 141.142. Nodari S. Effects of n-3 Polyunsaturated Fatty Acids on Left VentricularFunction and Functional Capacity in Patients With Dilated Cardiomyopathy/ S.Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M.
Cesana, M.Gheorghiade, L. Dei Cas // Journal of the American College of Cardiology. – 2011.– V. 57. – № 7. – Р. 870 – 879.143. Nodari S. Omega – 3 polyunsaturated fatty acids in the prevention of atrialfibrillation recurrences after electrical cardioversion: a prospective randomizedstudy / S. Nodari, M. Triggiani, U. Campia et al. // Circulation. – 2011. – V. 124. –P.1100 –1106.144. Pitt B. Evaluation of the Postinfarct Patient / B.
Pitt // Circulation. – 1995. –V. 91. – № 6. – P. 1855 – 1860.145. Ponikowski P. 2016 ESC Guidelines for the diagnosis and treatment of acuteand chronic heart failure / P. Ponikowski, A. A. Voors, S. D. Anker, He´ctorBueno, J. G. F. Cleland et al.// European Heart Journal. – 2016. – V. 37. – №. 27. –P.
– 2129 – 2200.146. Ponikowski P. Heart Failure. Preventing Disease and Death Worldwide / P.Ponikowski, S.D. Anker, K.F. Alhabib, M.R. Cowie, T.L. Force, S. Hu, T.Jaarsma, H. Krum et al. // ESC Heart Failure. – 2014. – № 1. – Р. 4 – 25.147. Pound E. M. Partitioning of polyunsaturated fatty acids, which preventcardiac arrhythmias, into phospholipid cell membrane / E. M. Pound, J. X. Kang,A.
Leaf // Journal of Lipid Research. – 2001. – V. 42. – № 3. – Р. 346 – 351.149148. Quittan M. Cross-cultural adaptation of the minnesota living with heartfailure questionnaire for german-speaking patients / M. Quittan, G. F.Wiesinger, R. Crevenna, M. J. Nuhr, M. Posch, M.
Hülsmann, D. Müller, R.Pacher, V. Fialka-Moser // Journal of Rehabilitation Medicine. – 2001. – V. 33. –№ 4. – P. 182 – 186.149. Rector Tb. Assessment of patient outcome with the Minnesota Living withHeart Failure questionnaire: Reability and validity during a randomized, doublemind, placebo-controlled trial of pimobendan / Tb. Rector, J. Cohn // AmericanHeart Journal. – 1992.
– Vol. 124. – № 4. – P. 1017 – 1024.150. Rackley C. E. Clinical experience with glucose–insulin–potassium therapyin acute myocardial infarctuin / C. E. Rackley, R. O. Russel, W. J. Rogers, J. A.Mantle, H. G. McDaniel, S. E. Papapietro // American Heart Journal. – 1981. –V.102. – № 6. – P. 1038 – 1049.151. Rosenberg T. H. Fish food to calm the heart / T. H.
Rosenberg // The NewEngland Journal of Medicine. – 2002. – V. 346. – № 15. – Р. 1102 – 1103.152. Saravanan Р. Cardiovascular effects of marine omega-3 fatty acids / P.Saravanan, N. C. Davidson, E. B. Schmidt, P. C. Calder // Lancet. – 2010. – V.376. – № 9740.
– Р. 540 – 550.153. Sabbah H. N. Mitochondrial abnormalities in myocardium of dogs withchronic heart failure / H. N. Sabbah, V. Sharov, J. M. Riddle, T. Kono, M.Lesch, S. Goldstein // Journal of Molecular and Cellular Cardiology. – 1992. – V.24. – N. 11. – P. 1333-1347.154. Schaper J. Impairment of the myocardial ultrastructure and changes of thecytoskeleton in dilated cardiomyopathy / J.Schaper, R. Froede, S. Hein, A.Buck, H.
Hashizume et. al. // Circulation – 1991. – V. 83. – №. 2. – P. 504 – 514.155. Shechter M. Does magnesium have a role in the treatment of patients withcoronary artery disease? / M. Shecher // American Journal of CardiovascularDrugs. – 2003. – V.
3. – № 4. – С. 231 – 239.156. Shechter M.Magnesium and cardiovascular system / M. Shecher //Magnesium Research. – 2010. – V. 23. – №. 2. – P. 60 – 72.150157. Stanley W. C. Energy Metabolism in the Normal and Failing Heart:Potential for Therapeutic Interventions / W. C. Stanley, M. P. Chandler // HeartFailure Reviews. – 2002. – V. 7. – № 2. – P. 115 – 130.158. Stanley W. C. Metabolic link between ischemia and cardiac dysfunction //Heart and Metabolism. – 2005. – № 27.
– Р. 30 – 33.159. Sodi–Pallares D.. Effects of an intravenous infusion of a potassium–insulin–glucose solution on the electrocardiographuc signs of myocardial infarction / D.Sodi–Pallares, M. Testelli, F. Fishleder // American Journal of Cardiology.
– 1962.– V. 9. – P. 166 – 181.160. Tavazzi L. Epidemiological burden of heart failure / L. Tavazzi // Heart. –1998. – V. 79. – № 2. – P. 6 – 9.161. Tang W. H. Polyunsaturated Fatty Acids in Heart Failure: Should We GiveMore and Give Earlier? / W. H. Tang, M. A. Samara // Journal of the AmericanCollege of Cardiology. – 2011. – V. 57. – № 7. – Р. 880 – 883.162. Taegtmeyer H.
Metabolism--the lost child of cardiology / H. Taegtmeyer //JACC. – 2000. – V. 36. – №. 4. – P. 1386 – 1388.163. Toma M. The relationship between left ventricular ejection fraction andmortality in patients with acute heart failure: Insights from the ASCEND-HF Trial.M.
Toma, J.A. Ezekowitz, J.A. Bakal, C.M. O’Connor, A.F. Hernandez, M.R.Sardar et al. // European Journal of Heart Failure. – 2014. – № 16. – Р. 334 – 341.164. Ussher J. R. Clinical implications of energetic problems in cardiovasculardisease / J. R. Ussher, G. D. Lopaschuk // Heart and Metabolism. – 2006. – № 32.– Р. 9 – 17.165. Ventura-Clapier R. Energy metabolism in heart failure / R. Ventura-Clapier,A. Garnier, V.
Veksler // The Journal of Physiology. – 2004. – V. 555. – № 1. – P.1 – 13.166. Von Schacky C. Cardiovascular benefits of omega-3 fatty acids / C. vonSchacky, W. S. Harris // Cardiovascular Research. – 2007. – V. 73. – № 2. – Р. 310– 315.151167. Wang Q. Effect of omega-3 fatty acids supplementation on endothelialfunction: a meta-analysis of randomized controlled trials / Q.
Wang, X. Liang, L.Wang, X. Lu, J. Huang, J. Cao, H. Li, D. Gu // Atherosclerosis. – 2012. – № 221. –P. 536 – 543.168. Wang C. The Role of Omega-3 Polyunsaturated Fatty Acids in HeartFailure: A Meta-Analysis of Randomised Controlled Trials / C. Wang, B. Xiong, J.Huang//Nutrients.–2017.–№9.doi:10.3390/nu9010018www.mdpi.com/journal/nutrients169. Xin W. Effects of fish oil supplementation on cardiac function in chronicheart failure: A meta-analysis of randomised controlled trials / W.
Xin, W. Wei, X.Li // Heart. – 2012. – № 98. – Р. 1620 – 1625.170. Yokoyama M. Effects of eicosapentaenoic acid on major coronary events inhypercholesterolaemic patients (JELIS): a randomised open-label, blindedendpoint analysis / M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y.Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H.
Hishida, H. Itakura, T. Kita, A.Kitabatake, N. Nakaya, T. Sakata, K. Shimada, K. Shirato; Japan EPA lipidintervention study (JELIS) Investigators. // Lancet. – 2007. – V. 369. – № 9567 –Р. 1090–1098.152.